
Randall L. Green
Examiner (ID: 4554)
| Most Active Art Unit | 3405 |
| Art Unit(s) | 2899, 3401, 1106, 3402, 2602, 3405, 2401, 3404, 3734, 3308 |
| Total Applications | 761 |
| Issued Applications | 670 |
| Pending Applications | 0 |
| Abandoned Applications | 91 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18610867
[patent_doc_number] => 20230277597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => HAPLOIDENTICAL MIXED CHIMERISM FOR TREATING AUTOIMMUNE DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/170913
[patent_app_country] => US
[patent_app_date] => 2023-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18170913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/170913 | HAPLOIDENTICAL MIXED CHIMERISM FOR TREATING AUTOIMMUNE DISEASES | Feb 16, 2023 | Pending |
Array
(
[id] => 18530207
[patent_doc_number] => 20230235277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => 3D Tissue Culture Materials and Processes for Producing Same
[patent_app_type] => utility
[patent_app_number] => 18/101751
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5975
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18101751
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/101751 | 3D Tissue Culture Materials and Processes for Producing Same | Jan 25, 2023 | Abandoned |
Array
(
[id] => 18842776
[patent_doc_number] => 20230405180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => MESENCHYMAL STEM CELL-HYDROGEL-BIODEGRADABLE OR MESENCHYMAL STEM CELL-HYDROGEL-UNDEGRADABLE SUPPORT COMPOSITION FOR SKIN REGENERATION OR WOUND HEALING
[patent_app_type] => utility
[patent_app_number] => 18/158215
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158215
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/158215 | MESENCHYMAL STEM CELL-HYDROGEL-BIODEGRADABLE OR MESENCHYMAL STEM CELL-HYDROGEL-UNDEGRADABLE SUPPORT COMPOSITION FOR SKIN REGENERATION OR WOUND HEALING | Jan 22, 2023 | Pending |
Array
(
[id] => 18567436
[patent_doc_number] => 20230257769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => TRANSGENIC PHOTORECEPTORS AND THEIR USE IN VISION TREATMENT
[patent_app_type] => utility
[patent_app_number] => 18/098328
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18098328
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/098328 | TRANSGENIC PHOTORECEPTORS AND THEIR USE IN VISION TREATMENT | Jan 17, 2023 | Pending |
Array
(
[id] => 18483604
[patent_doc_number] => 20230210904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PHARMACEUTICAL CONTAINING HELPER T CELLS INDUCED FROM PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/145476
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145476 | PHARMACEUTICAL CONTAINING HELPER T CELLS INDUCED FROM PLURIPOTENT STEM CELLS | Dec 21, 2022 | Pending |
Array
(
[id] => 18483604
[patent_doc_number] => 20230210904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PHARMACEUTICAL CONTAINING HELPER T CELLS INDUCED FROM PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/145476
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11884
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145476
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145476 | PHARMACEUTICAL CONTAINING HELPER T CELLS INDUCED FROM PLURIPOTENT STEM CELLS | Dec 21, 2022 | Pending |
Array
(
[id] => 18536031
[patent_doc_number] => 20230241118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => REJUVENATION TREATMENT OF AGE-RELATED WHITE MATTER LOSS
[patent_app_type] => utility
[patent_app_number] => 18/047831
[patent_app_country] => US
[patent_app_date] => 2022-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45577
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18047831
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/047831 | REJUVENATION TREATMENT OF AGE-RELATED WHITE MATTER LOSS | Oct 18, 2022 | Pending |
Array
(
[id] => 18211721
[patent_doc_number] => 20230057984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => NORMALIZATION OF CULTURE OF CORNEAL ENDOTHELIAL CELLS
[patent_app_type] => utility
[patent_app_number] => 17/936261
[patent_app_country] => US
[patent_app_date] => 2022-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936261
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936261 | NORMALIZATION OF CULTURE OF CORNEAL ENDOTHELIAL CELLS | Sep 27, 2022 | Abandoned |
Array
(
[id] => 18268659
[patent_doc_number] => 20230089901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PURIFIED MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF PURIFYING MESENCHYMAL STEM CELL COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/934852
[patent_app_country] => US
[patent_app_date] => 2022-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14449
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934852
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934852 | PURIFIED MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF PURIFYING MESENCHYMAL STEM CELL COMPOSITIONS | Sep 22, 2022 | Abandoned |
Array
(
[id] => 18193915
[patent_doc_number] => 20230047434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/894936
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894936 | COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE | Aug 23, 2022 | Pending |
Array
(
[id] => 18193915
[patent_doc_number] => 20230047434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE
[patent_app_type] => utility
[patent_app_number] => 17/894936
[patent_app_country] => US
[patent_app_date] => 2022-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17894936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/894936 | COMPOSITION FOR INDUCING CHONDROCYTE DIFFERENTIATION AND REGENERATING CARTILAGE TISSUE | Aug 23, 2022 | Pending |
Array
(
[id] => 18034632
[patent_doc_number] => 20220378847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817488
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817488 | ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY | Aug 3, 2022 | Abandoned |
Array
(
[id] => 18034632
[patent_doc_number] => 20220378847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/817488
[patent_app_country] => US
[patent_app_date] => 2022-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817488
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817488 | ADHERENT CELLS FROM ADIPOSE OR PLACENTA TISSUES AND USE THEREOF IN THERAPY | Aug 3, 2022 | Abandoned |
Array
(
[id] => 18349437
[patent_doc_number] => 20230137548
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => NEURAL STEM CELL-MEDIATED CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/811851
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811851
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811851 | NEURAL STEM CELL-MEDIATED CANCER TREATMENT | Jul 10, 2022 | Pending |
Array
(
[id] => 17828458
[patent_doc_number] => 20220265762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => COMPOSITION, COMPRISING TMEM176B OR AN EXPRESSION OR ACTIVITY REGULATOR THEREOF AS AN ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF DEGENERATIVE BRAIN DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/736442
[patent_app_country] => US
[patent_app_date] => 2022-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736442
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/736442 | COMPOSITION, COMPRISING TMEM176B OR AN EXPRESSION OR ACTIVITY REGULATOR THEREOF AS AN ACTIVE INGREDIENT, FOR PREVENTION OR TREATMENT OF DEGENERATIVE BRAIN DISEASE | May 3, 2022 | Pending |
Array
(
[id] => 17807728
[patent_doc_number] => 20220259563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHODS OF GENERATING NATURAL KILLER CELLS
[patent_app_type] => utility
[patent_app_number] => 17/733321
[patent_app_country] => US
[patent_app_date] => 2022-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17733321
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/733321 | METHODS OF GENERATING NATURAL KILLER CELLS | Apr 28, 2022 | Abandoned |
Array
(
[id] => 17774151
[patent_doc_number] => 20220240500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Cryopreservation compositions and methods involving nanowarming
[patent_app_type] => utility
[patent_app_number] => 17/726271
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726271 | Cryopreservation compositions and methods involving nanowarming | Apr 20, 2022 | Pending |
Array
(
[id] => 17774151
[patent_doc_number] => 20220240500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-04
[patent_title] => Cryopreservation compositions and methods involving nanowarming
[patent_app_type] => utility
[patent_app_number] => 17/726271
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726271 | Cryopreservation compositions and methods involving nanowarming | Apr 20, 2022 | Pending |
Array
(
[id] => 17759210
[patent_doc_number] => 20220232822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SOLUTIONS FOR INCREASING THE STABILITY AND SHELF LIFE OF AN ORGAN AND TISSUE PRESERVATION SOLUTION
[patent_app_type] => utility
[patent_app_number] => 17/684495
[patent_app_country] => US
[patent_app_date] => 2022-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5435
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17684495
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/684495 | SOLUTIONS FOR INCREASING THE STABILITY AND SHELF LIFE OF AN ORGAN AND TISSUE PRESERVATION SOLUTION | Mar 1, 2022 | Pending |
Array
(
[id] => 17658446
[patent_doc_number] => 20220178911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-09
[patent_title] => Synthetic Lethality Screening Platform for Cells Undergoing ALT
[patent_app_type] => utility
[patent_app_number] => 17/681714
[patent_app_country] => US
[patent_app_date] => 2022-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17681714
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/681714 | Synthetic Lethality Screening Platform for Cells Undergoing ALT | Feb 25, 2022 | Pending |